electroCore, Inc. - Common Stock (ECOR)
6.6200
+0.4300 (6.95%)
NASDAQ · Last Trade: Apr 2nd, 7:58 PM EDT
Via Benzinga · March 13, 2025

Via Benzinga · May 11, 2023
In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness.
Via Talk Markets · February 21, 2025

In this video lesson, I review the resilient overall market, stocks on my radar for the short and long-term portfolio, and a new EOD swing trade, for Tuesday's session. Happy trading. Aloha.
Via Talk Markets · February 14, 2025

Volatile market? Learn how RCAT, ROOT, and GEO stand out with robust catalysts, sentiment, and fundamentals.
Via Talk Markets · November 15, 2024

ECOR stock results show that electroCore beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024

Via Benzinga · March 10, 2023

ECOR stock results show that electroCore beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024

Via Benzinga · May 8, 2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via Benzinga · March 13, 2024

Via Benzinga · September 5, 2023

Via Benzinga · August 8, 2023

The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · August 4, 2023

Via Benzinga · July 27, 2023

electroCore, Inc.’s (NASDAQ: ECOR) gammaCore non-invasive vagus nerve stimulation (“nVNS”) has been selected to be a part of studies on effects of cannabinoids and alternative care on athlete pain management and perfor
Via Benzinga · July 6, 2023

Via Benzinga · March 16, 2023

With new economic data boding poorly for risk-on investments, investors should strongly consider targeting stocks to sell.
Via InvestorPlace · February 28, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.
Via Benzinga · February 27, 2023

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Via Benzinga · March 8, 2023